Business Development

Spin Offs

In line with major university hospitals in EU and worldwide, Ospedale San Raffaele has committed to developing its innovative projects also through the creation of dedicated companies, where investors, management teams, and investigators jointly address the translational process with combined science and managerial strenghts.

Business Development promotes the creation of new companies in the health sector and manages and supports, also through incubation services,  the current portfolio of San Raffaele’s start ups

Collectively, OSR’s start ups have raised over 50 mln Euro from private investors, public funding and venture capital as of 2020.

Contact: Rossana Roncarolo | roncarolo.rossana@hsr.it

Start Ups

GENENTA SCIENCE
Cancer immunogenetherapy

GENESPIRE
Gene therapy of genetic disorders

EPSILENBIO
Epigenetic silencing to treat human diseases

BIOREK
Biomarkers for screening, diagnosis and prognosis of renal carcinoma